PL3082805T3 - Podstawione amino-triazole i sposoby z ich użyciem - Google Patents
Podstawione amino-triazole i sposoby z ich użyciemInfo
- Publication number
- PL3082805T3 PL3082805T3 PL14871777T PL14871777T PL3082805T3 PL 3082805 T3 PL3082805 T3 PL 3082805T3 PL 14871777 T PL14871777 T PL 14871777T PL 14871777 T PL14871777 T PL 14871777T PL 3082805 T3 PL3082805 T3 PL 3082805T3
- Authority
- PL
- Poland
- Prior art keywords
- methods
- same
- substituted amino
- amino triazoles
- triazoles
- Prior art date
Links
- JSIAIROWMJGMQZ-UHFFFAOYSA-N 2h-triazol-4-amine Chemical class NC1=CNN=N1 JSIAIROWMJGMQZ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361919117P | 2013-12-20 | 2013-12-20 | |
| PCT/US2014/071490 WO2015095701A1 (en) | 2013-12-20 | 2014-12-19 | Substituted amino triazoles, and methods using same |
| EP14871777.0A EP3082805B1 (en) | 2013-12-20 | 2014-12-19 | Substituted amino triazoles, and methods using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3082805T3 true PL3082805T3 (pl) | 2020-09-21 |
Family
ID=53403739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14871777T PL3082805T3 (pl) | 2013-12-20 | 2014-12-19 | Podstawione amino-triazole i sposoby z ich użyciem |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10214531B2 (pl) |
| EP (1) | EP3082805B1 (pl) |
| JP (1) | JP2017501226A (pl) |
| CN (1) | CN106659715A (pl) |
| AU (1) | AU2014369053B2 (pl) |
| CA (1) | CA2937147A1 (pl) |
| PL (1) | PL3082805T3 (pl) |
| SG (1) | SG11201605757SA (pl) |
| WO (1) | WO2015095701A1 (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106659697B (zh) * | 2014-05-30 | 2022-03-29 | 斯菲叶尔制药私有公司 | 作为抗结核剂的化合物 |
| PL415073A1 (pl) * | 2014-12-19 | 2016-06-20 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków |
| ES2821896T3 (es) * | 2015-08-05 | 2021-04-28 | Indivior Uk Ltd | Antagonistas del receptor de dopamina D3 que tienen una unidad estructural biciclo |
| PL415078A1 (pl) | 2015-09-04 | 2017-03-13 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków |
| WO2019040107A1 (en) | 2017-08-21 | 2019-02-28 | Acadia Pharmaceuticals Inc. | COMPOUNDS, CORRESPONDING SALTS AND METHODS FOR THE TREATMENT OF DISEASES |
| US11440884B2 (en) * | 2017-08-21 | 2022-09-13 | Acadia Pharmaceuticals Inc. | Compounds, salts thereof and methods for treatment of diseases |
| CR20200464A (es) | 2018-03-08 | 2021-04-14 | Incyte Corp | Compuestos diólicos de aminopirazina como inhibidores de pi3k-y |
| CN108467395B (zh) * | 2018-05-09 | 2020-12-11 | 大连理工大学 | 一种几丁质酶抑制剂及其应用 |
| WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
| TW202116754A (zh) | 2019-07-11 | 2021-05-01 | 美商Ｅ 斯蓋普生物股份有限公司 | 作為ｌｒｒｋ２抑制劑之吲唑及氮雜吲唑 |
| JP7697933B2 (ja) * | 2019-09-25 | 2025-06-24 | オンコアレンディ セラピューティクス エス．エー． | ５－（４－（（２ｓ，５ｓ）－５－（４－クロロベンジル）－２－メチルモルホリノ）ピペリジン－１－イル）－１ｈ－１，２，４－トリアゾール－３－アミンの製造プロセス |
| CA3162526A1 (en) * | 2020-01-28 | 2021-08-05 | Christopher John Brown | Modulators of the integrated stress response pathway |
| CN111732571B (zh) * | 2020-07-24 | 2021-06-29 | 广西壮族自治区农业科学院 | 一种用于防治香蕉枯萎病的杀植物真菌剂 |
| CN114835687B (zh) * | 2021-04-02 | 2023-09-05 | 北京华森英诺生物科技有限公司 | AhR抑制剂 |
| MX2023014819A (es) | 2021-06-14 | 2024-03-21 | Scorpion Therapeutics Inc | Derivados de la urea que pueden ser utilizados para tratar el cancer. |
| EP4269400B1 (en) * | 2022-04-29 | 2025-07-09 | Molecure SA | Ykl-40 inhibitors and their therapeutic applications |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4421753A (en) | 1982-01-15 | 1983-12-20 | American Cyanamid Company | 1-(5-Amino-4H-1,2,4-triazol-3-yl)-4-substituted-piperazines |
| US4582833A (en) * | 1984-04-16 | 1986-04-15 | American Cyanamid Company | 2-(substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines |
| GB0325745D0 (en) * | 2003-11-05 | 2003-12-10 | Astrazeneca Ab | Chemical compounds |
| US8178533B2 (en) | 2005-06-01 | 2012-05-15 | Ucb Pharma, S.A. | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| US8288371B2 (en) | 2007-10-05 | 2012-10-16 | Pharmacopeia, Llc | Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation |
| ES2536442T3 (es) * | 2011-03-24 | 2015-05-25 | Janssen Pharmaceuticals, Inc. | Derivados novedosos de triazolil piperazina y triazolil piperidina como moduladores de la gamma secretasa |
-
2014
- 2014-12-19 AU AU2014369053A patent/AU2014369053B2/en active Active
- 2014-12-19 PL PL14871777T patent/PL3082805T3/pl unknown
- 2014-12-19 CA CA2937147A patent/CA2937147A1/en not_active Abandoned
- 2014-12-19 JP JP2016560862A patent/JP2017501226A/ja active Pending
- 2014-12-19 EP EP14871777.0A patent/EP3082805B1/en active Active
- 2014-12-19 WO PCT/US2014/071490 patent/WO2015095701A1/en not_active Ceased
- 2014-12-19 CN CN201480076075.6A patent/CN106659715A/zh active Pending
- 2014-12-19 US US15/037,090 patent/US10214531B2/en active Active
- 2014-12-19 SG SG11201605757SA patent/SG11201605757SA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20160297823A1 (en) | 2016-10-13 |
| JP2017501226A (ja) | 2017-01-12 |
| CA2937147A1 (en) | 2015-06-25 |
| EP3082805A1 (en) | 2016-10-26 |
| WO2015095701A1 (en) | 2015-06-25 |
| AU2014369053A1 (en) | 2016-07-28 |
| EP3082805B1 (en) | 2020-02-05 |
| SG11201605757SA (en) | 2016-08-30 |
| EP3082805A4 (en) | 2017-05-10 |
| AU2014369053B2 (en) | 2019-03-14 |
| US10214531B2 (en) | 2019-02-26 |
| CN106659715A (zh) | 2017-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276106A (en) | Garp-binding proteins and their uses | |
| SG11201605757SA (en) | Substituted amino triazoles, and methods using same | |
| AP2015008953A0 (en) | User authentication system and method | |
| GB201306633D0 (en) | Biaising circuitry and method thereof | |
| GB201319878D0 (en) | Method, Array and use thereof | |
| SG11201505864SA (en) | Beauty aid | |
| GB201312318D0 (en) | Novel methods and compounds | |
| IL244383A0 (en) | Triazolone compounds and their uses | |
| ZA201600015B (en) | Anti-fibrogenic compounds, methods and uses thereof | |
| IL239762B (en) | Selective nox-1 blocking peptides and their use | |
| GB201300376D0 (en) | Method and compound | |
| ZA201507580B (en) | Urea mixtures and methods for making and using same | |
| GB201308057D0 (en) | Protein | |
| ZA201601880B (en) | Hetero-transglycosylase and uses thereof | |
| SI3033532T1 (sl) | Vezni element, uporaba in postopek | |
| EP2952519A4 (en) | PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF | |
| GB201313803D0 (en) | Fungicidal composition and method | |
| GB201301728D0 (en) | Telcommunications apparatus and methods | |
| EP3089622A4 (en) | Uni-directional rigidifier and method | |
| GB201401955D0 (en) | Protein | |
| GB201301640D0 (en) | Methods and peptides | |
| GB201302030D0 (en) | Protein | |
| GB201304166D0 (en) | CelebQuiff and Instant Quiff | |
| GB201315295D0 (en) | Compound and method | |
| GB201315292D0 (en) | Compound and method |